Acute lung injury (ALI), a common and often lethal illness, is characterized by widespread and injurious inflammation. Many features of ALI, including its pathophysiology and therapeutic interventions remain incompletely defined, in part because the cellular and molecular mechanisms are poorly understood. Although the role of leukocytes in ALI has been well studied, investigations into platelet function in ALI have been relatively infrequent and there are many gaps in our knowledge. Recent evidence from our group and others suggests that platelets have important functions that contribute to the development and progression of ALI. Platelets are known to possess a transcriptome of messenger RNAs (mRNAs) that they receive from megakaryocytes. Unexpectedly, we recently demonstrated that megakaryocytes also transfer intron- containing pre-mRNAs to platelets. In response to activating signals, anucleate platelets splice these pre-mRNAs and reassembled them into mature mRNA transcripts which are translated into functional proteins. Two of the spliced mRNAs we have characterized code for interleukin-1? (IL-1?), an inflammatory cytokine, and tissue factor (TF), a regulator of coagulation. Both synthesized proteins have functional activity central to the pathobiology of ALI. In our preliminary data from sepsis patients (a risk factor for ALI), we demonstrated that the incidence of TF pre-mRNA splicing in platelets is markedly increased and predicts greater illness severity and higher mortality risk. These pilot data suggest a role for platelet-derived pre-mRNA splicing events in ALI. We now propose integrated clinical and basic science studies to explore these observations. A central hypothesis is that pre-mRNA splicing events in platelets are dysregulated in ALI, and that the expression of spliced messages in platelets provides predictive information in addition to contributing to pathologic sequellae. Two integrated specific aims will examine splicing patterns in (1) patients with ALI and (2) patients at-risk for ALI. These studies will generate new insights into the molecular pathobiology of ALI and may provide new targets for therapeutic interventions. Acute lung injury is a common disorder that results when the body's responses to infection become uncontrolled. Acute lung injury has high mortality and is a major public health issue. The studies proposed in this application explore newly-identified cellular and molecular mechanisms using samples from patients with this disorder and may yield new ways to chart the course of acute lung injury in individual patients, and have the potential to identify new molecular targets for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL091754-04
Application #
8018479
Study Section
Special Emphasis Panel (ZHL1-CSR-H (O1))
Program Officer
Harabin, Andrea L
Project Start
2008-02-01
Project End
2013-01-31
Budget Start
2011-02-01
Budget End
2013-01-31
Support Year
4
Fiscal Year
2011
Total Cost
$367,822
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Middleton, Elizabeth A; Rondina, Matthew T; Schwertz, Hansjorg et al. (2018) Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome. Am J Respir Cell Mol Biol 59:18-35
Rondina, Matthew T; Carlisle, McKenzie; Fraughton, Tamra et al. (2015) Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci 70:225-31
Hottz, Eugenio D; Medeiros-de-Moraes, Isabel M; Vieira-de-Abreu, Adriana et al. (2014) Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol 193:1864-72
Hottz, E D; Oliveira, M F; Nunes, P C G et al. (2013) Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost 11:951-62
Weyrich, Andrew S; Zimmerman, Guy A (2013) Platelets in lung biology. Annu Rev Physiol 75:569-91
Rondina, Matthew T; Weyrich, Andrew S; Zimmerman, Guy A (2013) Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 112:1506-19
Franks, Zechariah; Campbell, Robert A; Vieira de Abreu, Adriana et al. (2013) Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration. Thromb Haemost 109:684-95
Hottz, Eugenio D; Lopes, Juliana F; Freitas, Carla et al. (2013) Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 122:3405-14
Kraemer, Bjoern F; Campbell, Robert A; Schwertz, Hansjörg et al. (2012) Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood 120:5014-20
Rondina, Matthew T; Brewster, BreAnna; Grissom, Colin K et al. (2012) In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest 141:1490-1495

Showing the most recent 10 out of 30 publications